Investigating the immunosuppressive microenvironment created by acute myeloid leukaemia using invariant natural killer T cells as a novel therapeutic approach

Stavrou, Victoria (2022). Investigating the immunosuppressive microenvironment created by acute myeloid leukaemia using invariant natural killer T cells as a novel therapeutic approach. University of Birmingham. Ph.D.

[img]
Preview
Stavrou2022PhD.pdf
Text - Accepted Version
Available under License All rights reserved.

Download (4MB) | Preview

Abstract

Acute myeloid leukaemia (AML) creates an immunosuppressive microenvironment to conventional T cells through Arginase 2 (ARG2) inducing arginine depletion. We identify that AML blasts release the acute phase protein serum amyloid A (SAA), which acts in an autocrine manner to upregulate ARG2 expression and activity and promote AML blast viability.

Invariant natural killer T cells (iNKT) are a distinct population of T-cells with the unique ability to bridge the innate and adaptive immune system by mediating a range of immune responses and play a key role in tumour immunosurveillance. In AML the low level of iNKT cells post stem cell transplant is associated with poor overall survival; however it is unclear if iNKT cells directly regulate the growth of malignant cells. We establish that iNKT cells can detect and interact with AML blasts in a CD1d/CD40 dependent manner. α-GalCer-loaded AML blasts induce potent iNKT cell activation resulting in release IFN-γ and initiating clonal expansion in vivo and in vitro. Activated iNKT cells can reduce tumour burden by directly killing AML blasts via granzyme B pathway inducing apoptosis.

Despite the low arginine AML microenvironment which is hostile to T cells, iNKT cells retain their ability to proliferate, become activated and elicit a cytotoxic response against AML due to the upregulation of LAT-1 and ASS-1 dependent amino acid pathways. Finally, activated iNKT cells can further restore T cell proliferation both in vitro and in vivo.

This illustrates that iNKT cells are key players in creating an anti-leukemic response, thus, stimulation of iNKT cell activity has the potential to be exploited as an immunotherapeutic approach against AML or as an adjunct to boost antigen-specific T cell immunotherapies in cancers.

Type of Work: Thesis (Doctorates > Ph.D.)
Award Type: Doctorates > Ph.D.
Supervisor(s):
Supervisor(s)EmailORCID
De Santo, CarmelaUNSPECIFIEDUNSPECIFIED
Mussai, FrancisUNSPECIFIEDUNSPECIFIED
Licence: All rights reserved
College/Faculty: Colleges (2008 onwards) > College of Medical & Dental Sciences
School or Department: Institute of Immunology and Immunotherapy
Funders: None/not applicable
Subjects: Q Science > Q Science (General)
URI: http://etheses.bham.ac.uk/id/eprint/12559

Actions

Request a Correction Request a Correction
View Item View Item

Downloads

Downloads per month over past year